Article Details

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Receives Consensus Recommendation of "Buy" from ...

Retrieved on: 2020-12-17 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Receives Consensus Recommendation of "Buy" from .... View article details on hiswai:

Excerpt

The <b>biotechnology</b> company reported ($0.10) earnings per share for the ... safe manner to focus the patient's <b>immune system</b> to attack cancer cells.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up